NCT05010005 2025-12-03A Study of Ruxolitinib and Duvelisib in People With LymphomaMemorial Sloan Kettering Cancer CenterPhase 1 Recruiting70 enrolled
NCT01871675 2016-07-11Study of IPI-145 in Combination With Rituximab or Bendamustine/Rituximab in Hematologic MalignanciesSCRI Development Innovations, LLCPhase 1 Completed48 enrolled